Prevalence, Severity and Natural Course of Sleep Apnea After Cardiac Surgery
SDB-ZRW
1 other identifier
observational
450
1 country
1
Brief Summary
Sleep disordered breathing (SDB) is common in cardiovascular patients. Patients after cardiac surgery will be screened for SDB with the ApnoeLink device at the beginning of cardiac Rehabilitation and then after 3 weeks and 3 months.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 2016
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 2, 2015
CompletedFirst Posted
Study publicly available on registry
December 16, 2015
CompletedStudy Start
First participant enrolled
May 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2020
CompletedSeptember 2, 2026
September 1, 2026
2.3 years
December 2, 2015
September 1, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Change of SDB prevalence after cardiac surgery measured with ApnoeLink Air device
• Prevalence of sleep apnoe at day 1 and 20 of rehabilitation and 3 months after cardiac surgery assessed with the ApnoeLink Air device (ResMed)
day 1, day 20, 3 months
Study Arms (2)
cardiac surgery
active Group screening
orthopedic surgery
control Group screening
Interventions
Screening for sleep disordered breathing with the ApnoeLink Air device
Eligibility Criteria
cardiac surgery \< 2 weeks
You may qualify if:
- cardiac surgery or orthopedic surgery \<2 weeks
You may not qualify if:
- known SDB
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Zürcher RehaZentrum Wald
Wald, 8636, Switzerland
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Matthias Hermann, MD
Zürcher RehaZentrum Wald
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 2, 2015
First Posted
December 16, 2015
Study Start
May 1, 2016
Primary Completion
August 1, 2018
Study Completion
December 1, 2020
Last Updated
September 2, 2026
Record last verified: 2026-09